OMNIUM Global

Omnium Global’s vision is to de-risk products commercialization to maximize impact on global health. Most Life Science startups fail before reaching approvals & having an impact on patients. Omnium helps companies beat these odds by reducing risks, timelines, & costs associated with product commercialization. We do this by working side by side at critical growth points focused on driving immediate results in both commercial and scientific operations. Our track record reflects our expertise, with successful launches of diverse biopharmaceuticals spanning recombinant proteins, vaccines, cell/gene/oncolytic virus therapies, impacting over 20 countries. We boast >50 approved INDs, 150+ publications & invited conference presentations, and over $750m in commercial agreements closed. We Support: Life Sciences Companies: Optimize Marketing & Commercialization Strategy Biotech Companies: Decrease Risk, Costs, & Time to Market CDMOs: Implement Robust Processes, Improve Execution, Increase Profitability Investors: Make Informed Investments & Improve Returns Commercial Operations: Strategy & Corporate Development: Executing your vision, strategizing marketing, fundraising, product launches, exit strategies Marketing & Communications: Market intelligence, branding, thought leadership, content development Business Development: Identifying targets, lead engagement, proposal generation Business Operations: Portfolio strategy, capacity management, metrics development, program management Scientific Operations: Process & Analytical Development: Product development, scale-up, commercialization Quality, CMC, & Outsourcing: Ensuring compliance, CDMO sourcing, due diligence, service provider management, RFP creation Programs Management: Project planning, risk mitigation, meeting timelines, stakeholder coordination, supply chain management Facility Design & Procurement: Engineering design, equipment sizing, gap analysis, commercial negotiations, facility auditing